社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Moderna, Inc.(MRNA)
盘后
52.58
0.02
+0.04%
19:09 EDT
52.56
-0.83
-1.55%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
小虎老师
·
03-09
周评:地缘催化美股连跌两周,油价与VIX飙升,美元与债券收益率反弹
上周回顾 1. 美国市场——地缘政治冲击波驱动避险资金涌入 美国、以色列与伊朗之间的地缘政治紧张局势,以及随之而来的油价飙升,已显著影响市场动态。黄金和白银等避险资产也随之上涨,投资者寻求躲避不确定性。 负面催化剂:受中东冲突、油价上涨以及令人失望的月度就业报告拖累,美股指数连续第二周下跌。
$道琼斯(.DJI)$
2.9%,
$标普500(.SPX)$
回落2.0%,
$纳斯达克(.IXIC)$
收跌1.2%。 新兴市场抛售:避险情绪重创国际股市;MSCI EAFE指数和MSCI新兴市场指数均暴跌近7%。 油价飙升:不断升级的军事冲突席卷中东,推动油价升至2023年9月以来最高水平。 VIX跳涨:
$标普500波动率指数(VIX)$
收于29.5,较前一周收盘水平上涨48%。 美元与收益率逆转:周五,10年期美国国债收益率
$10年美债主连 2606(ZNmain)$
收于4.15%,高于前一周的3.96%。同时,
$美元指数(USDindex.FOREX)$
在避险资金涌入背景下走强。 四季度财报:根据FactSet数据,标普500指数成分股公司公布的平均盈利较上年同期增长14.0%。 通胀观察:投资者本周关键关注消费者物价指数(周三)和个人消费支出物价指数(周五)或将指
周评:地缘催化美股连跌两周,油价与VIX飙升,美元与债券收益率反弹
回复
评论
点赞
10
编组 21备份 2
分享
举报
投阅笔记
·
03-05
Moderna发布2025年财报:全年亏损28亿美元,但2026年增长预期达10%
$Moderna, Inc.(MRNA)$
2026年2月13日Moderna公布2025年第四季度财务业绩及业务进展。 业绩概要: 第四季度营收7亿美元,公认会计准则净亏损8亿美元,每股收益亏损2.11美元 全年营收19亿美元,公认会计准则净亏损28亿美元,公认会计准则摊薄每股收益亏损7.26美元 重申2026年营收增长目标达10%,并计划削减GAAP运营支出 宣布流感疫苗获欧盟、加拿大及澳大利亚监管机构受理;美国FDA发出拒收函,公司已申请A类会议商讨后续路径(最新消息已经通过) 诺如病毒三期临床试验完成患者招募,数据读出预计于2026年完成 宣布肌层浸润性膀胱癌II期intismeran自体移植试验完成患者招募 2025年第四季度财务业绩 收入:2025年第四季度总收入达6.78亿美元,处于公司前期预期区间上限,主要由新冠疫苗销售驱动。其中美国市场产品销售额为2.64亿美元,国际市场为3.81亿美元。与2024年同期相比,第四季度收入下降30%,主要反映新冠疫苗销量较上年同期减少。 销售成本:2025年第四季度销售成本为4.52亿美元,包含第三方特许权使用费3400万美元及库存减值1.44亿美元。销售成本较2024年同期下降39%,主要反映合同制造业务收尾成本及库存减值减少。 研发费用:2025年第四季度研发费用为7.75亿美元,较2024年同期下降31%。主要因临床开发及生产成本降低所致,反映出大型III期呼吸系统项目逐步收尾、持续推进产品组合优先级调整以及全公司范围内的成本管控成效。 销售、一般及行政费用:2025年第四季度销售、一般及行政费用为3.08亿美元,较2024年同期下降12%。主要源于多职能领域咨询及外部服务支出缩减,体现公司持续践行成本管控原则。 所得税:由于公司继续对大
Moderna发布2025年财报:全年亏损28亿美元,但2026年增长预期达10%
精彩
BerthaAntoinette:
亏28亿但明年预期10%增长,疫苗获批,等等看数据。
回复
1
点赞
点赞
编组 21备份 2
分享
举报
投阅笔记
·
03-01
美股实盘(28):-56%到-17.39%
$Figma(FIG)$
$Aurora Innovation(AUR)$
$Tempus AI(TEM)$
$Moderna, Inc.(MRNA)$
$Nu Holdings Ltd.(NU)$
先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十八篇: 1、收益率 总收益率 如上图所示,目前账户总收益来到了+822.13%,收益率相比上次增长,上次是+789.44%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为+3.59%,期间纳斯达克-2.44%,相对收益+6.03%。 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 最新持仓记录: 如上所示目前持仓6个股票,持仓公司相比上次减少1个,清仓公司就是Cloudflare,之后把这些资金全部买入了Aurora,所以该公司持仓相比上次大幅增长:9.48%到20.98%,这次考虑是我认为Aurora主营业务自动驾驶卡车拐点已经到了,股价未来上升空间远远大于Cloudflare。 对了还有其他操作,就是减持Tempus、NU、Modrna,这次资金全部增持Figma,上篇文章说了:如果该公司继续下跌,我会进一步增持。由于我是满仓操作,所以就只能减持其他股票加仓Figma,具体时间是在2月3日,那时候该公司最低跌到20.94,相比我的持仓成本,Figma亏损达到了
美股实盘(28):-56%到-17.39%
回复
评论
点赞
1
编组 21备份 2
分享
举报
萨姆哥哥
·
02-13
$Moderna, Inc.(MRNA)$
高开低走大概率
$Moderna, Inc.(MRNA)$ 高开低走大概率
回复
评论
点赞
1
编组 21备份 2
分享
举报
直击业绩会
·
02-10
【直播预告】本周财报日历|直击业绩会(2.9-2.13)
👉 欢迎订阅直播,直击高管解读财报与分析师Q&A 📊 本周财报季重点公司已出炉,本周将转播以下业绩会: 🎯 直播场次:Coinbase|周五 06:30 📍 直播入口:
Coinbase 2025Q4业绩电话会议
港美股财报季继续!
$中芯国际(00981)$
、华虹半导体、Robinhood、Coinbase、AppLovin等公司放榜 本周,美股传统行业股票例如
$可口可乐(KO)$
、
$T-Mobile US(TMUS)$
、
$英国石油(BP)$
等公司将业绩,医药巨头
$阿斯利康(AZN)$
、
$Moderna(MRNA)$
也将发布财报。 上周市场大跌,投资者将集中关注于近期剧烈波动的AI应用与软件股板块以及关键科技公司,投资者可关注
$Applovin(APP.US)$
和
$Unity Software(U)
【直播预告】本周财报日历|直击业绩会(2.9-2.13)
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
投阅笔记
·
02-01
美股实盘(27):亏损继续扩大
$Moderna, Inc.(MRNA)$
$Cloudflare, Inc.(NET)$
$Figma(FIG)$
$Recursion Pharmaceuticals, Inc.(RXRX)$
$Aurora Innovation(AUR)$
先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十七篇: 1、收益率 总收益率 图片 如上图所示,目前账户总收益来到了+789.44%,收益率相比上次大幅回撤,上次是+860.49%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为-0.09%,期间纳斯达克-0.98%,相对收益+0.89%。 图片 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 图片 最新持仓记录: 图片 如上所示目前持仓7个股票,持仓公司相比增加1个,具体公司就是Aurora,这次通过减持Moderna持仓,具体数量是50%的Moderna,然后全部买入Aurora。、 同时可以看到上次增持的Figma继续大幅下跌,持仓亏损继续扩大,从上次的-21.34%到-45.98%,怎么说呢?该公司最初作为基于浏览器的用户界面设计工具诞生,如今Figma的平台已扩展为助力团队实现从创意到产品全流程的一站式解决方案。该公司的产品有助于缩短软件开发时间。Figma首席执行官DylanField说过在人工智能
美股实盘(27):亏损继续扩大
精彩
Cliff:
亏得肉疼,持仓真磨人!
回复
5
点赞
12
编组 21备份 2
分享
举报
Eric.Hz
·
01-22
$Moderna, Inc.(MRNA)$
$Moderna, Inc.(MRNA)$
回复
评论
点赞
3
编组 21备份 2
分享
举报
我是股神大腿毛
·
01-22
$MRNA 20270115 65.0 CALL$
拿到100
$MRNA 20270115 65.0 CALL$ 拿到100
回复
评论
点赞
2
编组 21备份 2
分享
举报
等也是一种策略 如何等在哪里等
·
02-01
2026的第一个月其实已经颇疯狂,美股市场的核心叙事:资金从高估值纯软体股大规模轮动至AI硬体基础设施、记忆体存储与能源板块。 #赢家阵营:AI基础设施全面爆发 记忆体与存储产业(SNDK、MU、STX、WDC) SanDisk以惊人的142%涨幅领跑整个市场,这反映的是AI数据中心对企业级SSD需求的爆发性成长。2026年AI模型训练与推理已进入全面商用化阶段,市场不再争论AI是否会成长,而是聚焦于「算力、存储、电力谁先不够用」的问题。 SanDisk作为企业级固态硬碟主要的厂商之一,直接受益于这波升级潮,财报显示数据中心相关营收出现结构性跳升。 Micron上涨45%则是HBM(高频宽记忆体)供不应求的直接体现。HBM已成为AI训练不可或缺的关键零组件,而Micron是这个领域的主要供应商之一。市场过去将记忆体视为典型周期股,如今正重新将其定价为AI结构性成长标的。 Seagate与Western Digital同样上涨45%至48%,反映的是云端大规模存储扩建对近线硬碟的庞大需求,AI生成的数据量呈指数级成长,冷存储需求随之暴增。 半导体设备(LRCX) Lam Research上涨36%受益于先进制程与记忆体资本支出的双重复苏。这家公司高度暴露于NAND与DRAM设备市场,当记忆体厂商重启扩产,设备订单自然满载。地缘政治因素反而强化了「在地制造」的设备需求,各国建立本土半导体产能的政策进一步推升订单能见度。 #AI电力与能源链(BE、CCJ、IREN、VG) Bloom Energy以74%的涨幅位居第二,核心逻辑是AI数据中心「缺电」已成为新的产业瓶颈。其固态氧化物燃料电池特别适合数据中心的备用与分散式供电场景,在电网容量不足的情况下提供关键补充。Hyperscaler与主权AI专案同步扩张,但电力基础设施的建设速度远跟不上算力扩张,这让Bloom Energy的
2026的第一个月其实已经颇疯狂,美股市场的核心叙事:资金从高估值纯软体股大规模轮动至AI硬体基础设施、记忆体存储与能源板块。 #赢家阵营:AI基础设施全...
回复
评论
点赞
1
编组 21备份 2
分享
举报
投阅笔记
·
01-22
$Moderna, Inc.(MRNA)$
Moderna, Inc.公布的最新五年随访数据显示,其研发的Intismeran Autogene与默沙东的Keytruda(帕博利珠单抗)联合疗法,在主要临床终点指标上展现出持续性的改善效果。这一长期研究结果进一步验证了该组合疗法在相应适应症中的治疗潜力与持久性优势。
$Moderna, Inc.(MRNA)$ Moderna, Inc.公布的最新五年随访数据显示,其研发的Intismeran Autogene与默沙东的...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Moderna, Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.modernatx.com;www.investors.modernatx.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸(信使核糖核酸)医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年,该公司以前所未有的速度和效率开发出药物,包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队,以负责任的方式改变人类健康的未来,该公司努力通过mRNA药物向人们传递尽可能大的影响。
03-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
03-02
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
02-23
关联方拟减持公告
Form 144 | Moderna高管Hoge Stephen拟减持160009股,总价约781.5万美元
Form 144 | Moderna高管Hoge Stephen拟减持160009股,总价约781.5万美元
02-20
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
02-20
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
02-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
02-11
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-12-11
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-12-09
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
2025-11-25
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-20
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-06
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
分时
5日
日
周
月
数据加载中...
最高
55.09
今开
54.31
量比
0.71
最低
51.44
昨收
53.39
换手率
1.82%
热议股票
{"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"MRNA","data":{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":52.56,"timestamp":1773432000000,"preClose":53.39,"halted":0,"volume":6603739,"hourTrading":{"tag":"盘后","latestPrice":52.58,"preClose":52.56,"latestTime":"19:09 EDT","volume":122413,"amount":6433611.320626,"timestamp":1773443351475,"change":0.02,"changeRate":0.000381,"amplitude":0.012367},"delay":0,"changeRate":-0.015545982393706654,"floatShares":363290461,"shares":394939400,"eps":-7.26,"marketStatus":"盘后交易","change":-0.83,"latestTime":"03-13 19:10:44 EDT","open":54.31,"high":55.09,"low":51.44,"amount":348507854.993697,"amplitude":0.068365,"askPrice":52.75,"askSize":400,"bidPrice":52.58,"bidSize":44,"shortable":3,"etf":0,"ttmEps":-7.26,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1773446400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1544158800000,"exchange":"NASDAQ","adjPreClose":53.39,"preHourTrading":{"tag":"盘前","latestPrice":54.22,"preClose":53.39,"latestTime":"09:29 EDT","volume":23233,"amount":1249757.8998800002,"timestamp":1773408571079,"change":0.83,"changeRate":0.015546,"amplitude":0.022663},"postHourTrading":{"tag":"盘后","latestPrice":52.58,"preClose":52.56,"latestTime":"19:09 EDT","volume":122413,"amount":6433611.320626,"timestamp":1773443351475,"change":0.02,"changeRate":0.000381,"amplitude":0.012367},"volumeRatio":0.706868,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1773374400000,"strike":"55.0","timestamp":1773428247696,"price":0.03,"volume":4000,"amount":12000,"type":"-"},{"symbol":"MRNA","call":true,"expireDate":1773979200000,"strike":"53.0","timestamp":1773428247696,"price":2,"volume":4000,"amount":800000,"type":"+"}]},"impliedVol":0.7781,"impliedVolPercentile":0.5538},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.540760311623968","cardData":[{"tweetId":"540760311623968","author":{"authorId":"36989258284800","idStr":"36989258284800","name":"小虎老师","avatar":"https://static.laohu8.com/6e9d88ae16a2b401169a727cf1457404","userType":8,"introduction":"老虎国际官方账号","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":39210,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"周评:地缘催化美股连跌两周,油价与VIX飙升,美元与债券收益率反弹","digest":"上周回顾 1. 美国市场——地缘政治冲击波驱动避险资金涌入 美国、以色列与伊朗之间的地缘政治紧张局势,以及随之而来的油价飙升,已显著影响市场动态。黄金和白银等避险资产也随之上涨,投资者寻求躲避不确定性。 负面催化剂:受中东冲突、油价上涨以及令人失望的月度就业报告拖累,美股指数连续第二周下跌。 <a href=\"https://laohu8.com/S/.DJI\">$道琼斯(.DJI)$</a> 2.9%, <a href=\"https://laohu8.com/S/.SPX\">$标普500(.SPX)$</a> 回落2.0%, <a href=\"https://laohu8.com/S/.IXIC\">$纳斯达克(.IXIC)$</a> 收跌1.2%。 新兴市场抛售:避险情绪重创国际股市;MSCI EAFE指数和MSCI新兴市场指数均暴跌近7%。 油价飙升:不断升级的军事冲突席卷中东,推动油价升至2023年9月以来最高水平。 VIX跳涨: <a href=\"https://laohu8.com/S/VIX\">$标普500波动率指数(VIX)$</a> 收于29.5,较前一周收盘水平上涨48%。 美元与收益率逆转:周五,10年期美国国债收益率 <a href=\"https://laohu8.com/FUT/ZNmain\">$10年美债主连 2606(ZNmain)$</a> 收于4.15%,高于前一周的3.96%。同时, <a href=\"https://laohu8.com/S/USDindex.FOREX\">$美元指数(USDindex.FOREX)$</a> 在避险资金涌入背景下走强。 四季度财报:根据FactSet数据,标普500指数成分股公司公布的平均盈利较上年同期增长14.0%。 通胀观察:投资者本周关键关注消费者物价指数(周三)和个人消费支出物价指数(周五)或将指","plainDigest":"上周回顾 1. 美国市场——地缘政治冲击波驱动避险资金涌入 美国、以色列与伊朗之间的地缘政治紧张局势,以及随之而来的油价飙升,已显著影响市场动态。黄金和白银等避险资产也随之上涨,投资者寻求躲避不确定性。 负面催化剂:受中东冲突、油价上涨以及令人失望的月度就业报告拖累,美股指数连续第二周下跌。 $道琼斯(.DJI)$ 2.9%, $标普500(.SPX)$ 回落2.0%, $纳斯达克(.IXIC)$ 收跌1.2%。 新兴市场抛售:避险情绪重创国际股市;MSCI EAFE指数和MSCI新兴市场指数均暴跌近7%。 油价飙升:不断升级的军事冲突席卷中东,推动油价升至2023年9月以来最高水平。 VIX跳涨: $标普500波动率指数(VIX)$ 收于29.5,较前一周收盘水平上涨48%。 美元与收益率逆转:周五,10年期美国国债收益率 $10年美债主连 2606(ZNmain)$ 收于4.15%,高于前一周的3.96%。同时, $美元指数(USDindex.FOREX)$ 在避险资金涌入背景下走强。 四季度财报:根据FactSet数据,标普500指数成分股公司公布的平均盈利较上年同期增长14.0%。 通胀观察:投资者本周关键关注消费者物价指数(周三)和个人消费支出物价指数(周五)或将指","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1773047639249,"gmtModify":1773047716480,"symbols":["CRWD","AAOI","PLUG","02015","06618","ORCL","EB5.SI","NIO","MRNA","LEN","RIO","BBAI","LI","MRVL",".DJI","DG","VIX","XJO.AU","00100","COIN","CIEN","BS6.SI","MSFT","BILI","HSI","USDindex.FOREX","WDS","CRDO","F34.SI","AEM","TSM","02318","ASTS","09626","09866","INTC","C52.SI","ACHR","HSTECH","STO.AU","V03.SI","JD",".SPX","C6L.SI","ADBE","HPE","S63.SI","AVGO","TTD","BRK.B","BHP","CBA.AU","09618","02866","02228","01138","SE","9CI.SI","COST","STI.SI",".IXIC","NAB.AU","ZNmain","PNGAY","601318","601866","600026"],"themeIds":["fb0b8a84b3ed43f49e4a9bb328a89463","c7beb8c494764725b3b94f2f414bb12c","e4363384c4254650b897c0f13fe1588f","cc65bfe8ff7145cf8db4716572f98414"],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/7ac4780b7b3af7486696f6770ba545b2"},{"url":"https://static.tigerbbs.com/f06cf01e6fc1e5a229c86d044c239346"},{"url":"https://static.tigerbbs.com/7cad0a6f374fd59e2de09738facab3a7"}],"repostCount":0,"viewCount":16947,"likeCount":10,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/540760311623968","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":true,"upFlag":false,"length":7081,"displayRows":4,"foldSize":0,"authorId":"36989258284800"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.539227554152496","cardData":[{"tweetId":"539227554152496","author":{"authorId":"3551233200528073","idStr":"3551233200528073","name":"投阅笔记","avatar":"https://static.tigerbbs.com/880e7458e2b86083ea5fcaee8dd335ea","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.28","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3(或有料帖>=10),且30天内发表过至少一篇精华帖(或4篇有料帖)并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":2006,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"Moderna发布2025年财报:全年亏损28亿美元,但2026年增长预期达10%","digest":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> 2026年2月13日Moderna公布2025年第四季度财务业绩及业务进展。 业绩概要: 第四季度营收7亿美元,公认会计准则净亏损8亿美元,每股收益亏损2.11美元 全年营收19亿美元,公认会计准则净亏损28亿美元,公认会计准则摊薄每股收益亏损7.26美元 重申2026年营收增长目标达10%,并计划削减GAAP运营支出 宣布流感疫苗获欧盟、加拿大及澳大利亚监管机构受理;美国FDA发出拒收函,公司已申请A类会议商讨后续路径(最新消息已经通过) 诺如病毒三期临床试验完成患者招募,数据读出预计于2026年完成 宣布肌层浸润性膀胱癌II期intismeran自体移植试验完成患者招募 2025年第四季度财务业绩 收入:2025年第四季度总收入达6.78亿美元,处于公司前期预期区间上限,主要由新冠疫苗销售驱动。其中美国市场产品销售额为2.64亿美元,国际市场为3.81亿美元。与2024年同期相比,第四季度收入下降30%,主要反映新冠疫苗销量较上年同期减少。 销售成本:2025年第四季度销售成本为4.52亿美元,包含第三方特许权使用费3400万美元及库存减值1.44亿美元。销售成本较2024年同期下降39%,主要反映合同制造业务收尾成本及库存减值减少。 研发费用:2025年第四季度研发费用为7.75亿美元,较2024年同期下降31%。主要因临床开发及生产成本降低所致,反映出大型III期呼吸系统项目逐步收尾、持续推进产品组合优先级调整以及全公司范围内的成本管控成效。 销售、一般及行政费用:2025年第四季度销售、一般及行政费用为3.08亿美元,较2024年同期下降12%。主要源于多职能领域咨询及外部服务支出缩减,体现公司持续践行成本管控原则。 所得税:由于公司继续对大","plainDigest":"$Moderna, Inc.(MRNA)$ 2026年2月13日Moderna公布2025年第四季度财务业绩及业务进展。 业绩概要: 第四季度营收7亿美元,公认会计准则净亏损8亿美元,每股收益亏损2.11美元 全年营收19亿美元,公认会计准则净亏损28亿美元,公认会计准则摊薄每股收益亏损7.26美元 重申2026年营收增长目标达10%,并计划削减GAAP运营支出 宣布流感疫苗获欧盟、加拿大及澳大利亚监管机构受理;美国FDA发出拒收函,公司已申请A类会议商讨后续路径(最新消息已经通过) 诺如病毒三期临床试验完成患者招募,数据读出预计于2026年完成 宣布肌层浸润性膀胱癌II期intismeran自体移植试验完成患者招募 2025年第四季度财务业绩 收入:2025年第四季度总收入达6.78亿美元,处于公司前期预期区间上限,主要由新冠疫苗销售驱动。其中美国市场产品销售额为2.64亿美元,国际市场为3.81亿美元。与2024年同期相比,第四季度收入下降30%,主要反映新冠疫苗销量较上年同期减少。 销售成本:2025年第四季度销售成本为4.52亿美元,包含第三方特许权使用费3400万美元及库存减值1.44亿美元。销售成本较2024年同期下降39%,主要反映合同制造业务收尾成本及库存减值减少。 研发费用:2025年第四季度研发费用为7.75亿美元,较2024年同期下降31%。主要因临床开发及生产成本降低所致,反映出大型III期呼吸系统项目逐步收尾、持续推进产品组合优先级调整以及全公司范围内的成本管控成效。 销售、一般及行政费用:2025年第四季度销售、一般及行政费用为3.08亿美元,较2024年同期下降12%。主要源于多职能领域咨询及外部服务支出缩减,体现公司持续践行成本管控原则。 所得税:由于公司继续对大","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772668321079,"gmtModify":1772674629491,"symbols":["MRNA"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/e181340a882ef304939f98e8062a8708","width":"1280","height":"720"}],"repostCount":0,"viewCount":558,"likeCount":0,"liked":false,"collected":false,"commentCount":1,"hotComments":[{"id":"539269723616952","author":{"authorId":"9000000000000683","idStr":"9000000000000683","name":"BerthaAntoinette","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":8,"introduction":"运营账号","crmLevel":1,"crmLevelSwitch":0,"fanSize":0,"starInvestorFlag":false},"content":"亏28亿但明年预期10%增长,疫苗获批,等等看数据。","plainContent":"亏28亿但明年预期10%增长,疫苗获批,等等看数据。","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/539227554152496","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":5803,"displayRows":4,"foldSize":0,"authorId":"3551233200528073"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.537867839963976","cardData":[{"tweetId":"537867839963976","author":{"authorId":"3551233200528073","idStr":"3551233200528073","name":"投阅笔记","avatar":"https://static.tigerbbs.com/880e7458e2b86083ea5fcaee8dd335ea","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.28","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3(或有料帖>=10),且30天内发表过至少一篇精华帖(或4篇有料帖)并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":2006,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"美股实盘(28):-56%到-17.39%","digest":"<a href=\"https://laohu8.com/S/FIG\">$Figma(FIG)$</a> <a href=\"https://laohu8.com/S/AUR\">$Aurora Innovation(AUR)$</a> <a href=\"https://laohu8.com/S/TEM\">$Tempus AI(TEM)$</a> <a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> <a href=\"https://laohu8.com/S/NU\">$Nu Holdings Ltd.(NU)$</a> 先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十八篇: 1、收益率 总收益率 如上图所示,目前账户总收益来到了+822.13%,收益率相比上次增长,上次是+789.44%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为+3.59%,期间纳斯达克-2.44%,相对收益+6.03%。 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 最新持仓记录: 如上所示目前持仓6个股票,持仓公司相比上次减少1个,清仓公司就是Cloudflare,之后把这些资金全部买入了Aurora,所以该公司持仓相比上次大幅增长:9.48%到20.98%,这次考虑是我认为Aurora主营业务自动驾驶卡车拐点已经到了,股价未来上升空间远远大于Cloudflare。 对了还有其他操作,就是减持Tempus、NU、Modrna,这次资金全部增持Figma,上篇文章说了:如果该公司继续下跌,我会进一步增持。由于我是满仓操作,所以就只能减持其他股票加仓Figma,具体时间是在2月3日,那时候该公司最低跌到20.94,相比我的持仓成本,Figma亏损达到了","plainDigest":"$Figma(FIG)$ $Aurora Innovation(AUR)$ $Tempus AI(TEM)$ $Moderna, Inc.(MRNA)$ $Nu Holdings Ltd.(NU)$ 先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十八篇: 1、收益率 总收益率 如上图所示,目前账户总收益来到了+822.13%,收益率相比上次增长,上次是+789.44%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为+3.59%,期间纳斯达克-2.44%,相对收益+6.03%。 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 最新持仓记录: 如上所示目前持仓6个股票,持仓公司相比上次减少1个,清仓公司就是Cloudflare,之后把这些资金全部买入了Aurora,所以该公司持仓相比上次大幅增长:9.48%到20.98%,这次考虑是我认为Aurora主营业务自动驾驶卡车拐点已经到了,股价未来上升空间远远大于Cloudflare。 对了还有其他操作,就是减持Tempus、NU、Modrna,这次资金全部增持Figma,上篇文章说了:如果该公司继续下跌,我会进一步增持。由于我是满仓操作,所以就只能减持其他股票加仓Figma,具体时间是在2月3日,那时候该公司最低跌到20.94,相比我的持仓成本,Figma亏损达到了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772336275964,"gmtModify":1772341506551,"symbols":["FIG","TEM","MRNA","AUR","NU"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":6,"images":[{"url":"https://static.tigerbbs.com/e181340a882ef304939f98e8062a8708","width":"1280","height":"720"}],"repostCount":0,"viewCount":1286,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/537867839963976","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":11559,"displayRows":4,"foldSize":0,"authorId":"3551233200528073"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.532365592597544","cardData":[{"tweetId":"532365592597544","author":{"authorId":"3548294102254426","idStr":"3548294102254426","name":"萨姆哥哥","avatar":"https://static.tigerbbs.com/788a9bf830209fbeebdc48bca7fd8c75","userType":1,"introduction":"","crmLevel":7,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.02.12","exceedPercentage":"93.18%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$ </a> 高开低走大概率","plainDigest":"$Moderna, Inc.(MRNA)$ 高开低走大概率","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770992956085,"gmtModify":1770992958271,"symbols":["MRNA"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":428,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/532365592597544","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":4,"foldSize":0,"authorId":"3548294102254426"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.531120403443752","cardData":[{"tweetId":"531120403443752","author":{"authorId":"3515627051568386","idStr":"3515627051568386","name":"直击业绩会","avatar":"https://static.tigerbbs.com/6cc211c0c1b0a527888a896b6b9b0e33","userType":4,"introduction":"聚焦美港股财报业绩会,搬运业绩会中文字稿/视频","crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":6470,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"【直播预告】本周财报日历|直击业绩会(2.9-2.13)","digest":"👉 欢迎订阅直播,直击高管解读财报与分析师Q&A 📊 本周财报季重点公司已出炉,本周将转播以下业绩会: 🎯 直播场次:Coinbase|周五 06:30 📍 直播入口:<a href=\"https://laohu8.com/RN?name=RNLive&rndata=%7B%22liveId%22:%221856121037545803%22,%22type%22:2%7D\" target=\"_blank\">Coinbase 2025Q4业绩电话会议</a> 港美股财报季继续!<a href=\"https://laohu8.com/S/00981\">$中芯国际(00981)$</a>、华虹半导体、Robinhood、Coinbase、AppLovin等公司放榜 本周,美股传统行业股票例如<a href=\"https://laohu8.com/S/KO\">$可口可乐(KO)$</a>、<a href=\"https://laohu8.com/S/TMUS\">$T-Mobile US(TMUS)$</a>、<a href=\"https://laohu8.com/S/BP\">$英国石油(BP)$</a>等公司将业绩,医药巨头<a href=\"https://laohu8.com/S/AZN\">$阿斯利康(AZN)$</a> 、 <a href=\"https://laohu8.com/S/MRNA\">$Moderna(MRNA)$</a>也将发布财报。 上周市场大跌,投资者将集中关注于近期剧烈波动的AI应用与软件股板块以及关键科技公司,投资者可关注<a href=\"https://laohu8.com/S/APP.US\">$Applovin(APP.US)$</a>和<a href=\"https://laohu8.com/S/U\">$Unity Software(U)</a>","plainDigest":"👉 欢迎订阅直播,直击高管解读财报与分析师Q&A 📊 本周财报季重点公司已出炉,本周将转播以下业绩会: 🎯 直播场次:Coinbase|周五 06:30 📍 直播入口:Coinbase 2025Q4业绩电话会议 港美股财报季继续!$中芯国际(00981)$、华虹半导体、Robinhood、Coinbase、AppLovin等公司放榜 本周,美股传统行业股票例如$可口可乐(KO)$、$T-Mobile US(TMUS)$、$英国石油(BP)$等公司将业绩,医药巨头$阿斯利康(AZN)$ 、 $Moderna(MRNA)$也将发布财报。 上周市场大跌,投资者将集中关注于近期剧烈波动的AI应用与软件股板块以及关键科技公司,投资者可关注$Applovin(APP.US)$和$Unity Software(U)","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1770688402525,"gmtModify":1770688801545,"symbols":["KO","F","RIVN","00981","BP","COIN","01347","09999","TMUS","MRNA","AZN","U","HOOD","APP.US","688347","688981","NTES"],"themeIds":["e9fb75eed70244c7bb7cc18e8cbc862e"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/63d1423fd98b97bd8165369c1ba38866"}],"repostCount":0,"viewCount":12937,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/531120403443752","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":true,"upFlag":false,"length":762,"displayRows":4,"foldSize":0,"authorId":"3515627051568386"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.527943299048280","cardData":[{"tweetId":"527943299048280","author":{"authorId":"3551233200528073","idStr":"3551233200528073","name":"投阅笔记","avatar":"https://static.tigerbbs.com/880e7458e2b86083ea5fcaee8dd335ea","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.28","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3(或有料帖>=10),且30天内发表过至少一篇精华帖(或4篇有料帖)并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":2006,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"美股实盘(27):亏损继续扩大","digest":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a> <a href=\"https://laohu8.com/S/NET\">$Cloudflare, Inc.(NET)$</a> <a href=\"https://laohu8.com/S/FIG\">$Figma(FIG)$</a> <a href=\"https://laohu8.com/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$</a> <a href=\"https://laohu8.com/S/AUR\">$Aurora Innovation(AUR)$</a> 先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十七篇: 1、收益率 总收益率 图片 如上图所示,目前账户总收益来到了+789.44%,收益率相比上次大幅回撤,上次是+860.49%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为-0.09%,期间纳斯达克-0.98%,相对收益+0.89%。 图片 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 图片 最新持仓记录: 图片 如上所示目前持仓7个股票,持仓公司相比增加1个,具体公司就是Aurora,这次通过减持Moderna持仓,具体数量是50%的Moderna,然后全部买入Aurora。、 同时可以看到上次增持的Figma继续大幅下跌,持仓亏损继续扩大,从上次的-21.34%到-45.98%,怎么说呢?该公司最初作为基于浏览器的用户界面设计工具诞生,如今Figma的平台已扩展为助力团队实现从创意到产品全流程的一站式解决方案。该公司的产品有助于缩短软件开发时间。Figma首席执行官DylanField说过在人工智能","plainDigest":"$Moderna, Inc.(MRNA)$ $Cloudflare, Inc.(NET)$ $Figma(FIG)$ $Recursion Pharmaceuticals, Inc.(RXRX)$ $Aurora Innovation(AUR)$ 先说下美股实盘文章更新时间为每个月1号,如果1号是周六,那么更新就顺延一天。 本文是美股实盘第二十七篇: 1、收益率 总收益率 图片 如上图所示,目前账户总收益来到了+789.44%,收益率相比上次大幅回撤,上次是+860.49%,这是总的账户收益率,接下来看下今年以来的收益率,如下图所示,今年以来的收益率为-0.09%,期间纳斯达克-0.98%,相对收益+0.89%。 图片 接下来说下持仓个股。 2、持仓个股 上次持仓记录: 图片 最新持仓记录: 图片 如上所示目前持仓7个股票,持仓公司相比增加1个,具体公司就是Aurora,这次通过减持Moderna持仓,具体数量是50%的Moderna,然后全部买入Aurora。、 同时可以看到上次增持的Figma继续大幅下跌,持仓亏损继续扩大,从上次的-21.34%到-45.98%,怎么说呢?该公司最初作为基于浏览器的用户界面设计工具诞生,如今Figma的平台已扩展为助力团队实现从创意到产品全流程的一站式解决方案。该公司的产品有助于缩短软件开发时间。Figma首席执行官DylanField说过在人工智能","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769913302467,"gmtModify":1769913464545,"symbols":["FIG","MRNA","RXRX","NET","AUR"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":5,"images":[{"url":"https://static.tigerbbs.com/e181340a882ef304939f98e8062a8708","width":"1280","height":"720"}],"repostCount":0,"viewCount":17603,"likeCount":12,"liked":false,"collected":false,"commentCount":5,"hotComments":[{"id":"527952076575800","author":{"authorId":"9000000000000649","idStr":"9000000000000649","name":"Cliff","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":8,"introduction":"运营账号","crmLevel":1,"crmLevelSwitch":0,"fanSize":0,"starInvestorFlag":false},"content":"亏得肉疼,持仓真磨人!","plainContent":"亏得肉疼,持仓真磨人!","likeCount":0,"commentType":"hot","coins":0},{"id":"527958118044520","author":{"authorId":"4087422624240810","idStr":"4087422624240810","name":"AliceSam","avatar":"https://static.tigerbbs.com/77ff717dd7a06de56315c65060829a03","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":0,"fanSize":4494,"starInvestorFlag":true,"starInvestorFollowerNum":370},"content":"定期公开实盘的,都是勇士,佩服 [强]","plainContent":"定期公开实盘的,都是勇士,佩服 [强]","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/527943299048280","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":5648,"displayRows":4,"foldSize":0,"authorId":"3551233200528073"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.524780804289048","cardData":[{"tweetId":"524780804289048","author":{"authorId":"4203488005337362","idStr":"4203488005337362","name":"Eric.Hz","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.03.09","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$ </a> ","plainDigest":"$Moderna, Inc.(MRNA)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769096430698,"gmtModify":1769098725851,"symbols":["MRNA"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/7eef895632e66cb0e247a92412e823e2","width":"927","height":"1599"}],"repostCount":0,"viewCount":453,"likeCount":3,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/524780804289048","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":20,"displayRows":4,"foldSize":0,"authorId":"4203488005337362"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.524790835347800","cardData":[{"tweetId":"524790835347800","author":{"authorId":"320642945183470","idStr":"320642945183470","name":"我是股神大腿毛","avatar":"https://static.laohu8.com/279c4665f3b5baf86875c8fd7c8b4a20","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":9,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"d5d1b81d9a9a4306a42a1560851c3454-5","templateUuid":"d5d1b81d9a9a4306a42a1560851c3454","name":"Live trading challenger","description":"for 10 months","bigImgUrl":"https://static.tigerbbs.com/de3f2938b1f9dddd923333ef958535f5","smallImgUrl":"https://static.tigerbbs.com/a6b8bf4481e36ae8a863eae5098461e6","grayImgUrl":"https://static.tigerbbs.com/91c1c1e4d3607b46e414ab97cc6dd982","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.08.03","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":1160,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/OPT/MRNA 20270115 65.0 CALL\">$MRNA 20270115 65.0 CALL$</a> 拿到100","plainDigest":"$MRNA 20270115 65.0 CALL$ 拿到100","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769094152224,"gmtModify":1769094164333,"symbols":["MRNA","MRNA 20270115 65.0 CALL"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/e2d252e1d520bfa2ae78326f5e763fdc","width":"1122","height":"1737"}],"repostCount":0,"viewCount":931,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/524790835347800","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":29,"displayRows":4,"foldSize":0,"authorId":"320642945183470"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.528074237904056","cardData":[{"tweetId":"528074237904056","author":{"authorId":"4192713077052572","idStr":"4192713077052572","name":"等也是一种策略 如何等在哪里等","avatar":"https://static.tigerbbs.com/120755ba038fdcb70c2bb1d2816ad8f1","userType":1,"introduction":"","crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":582,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"2026的第一个月其实已经颇疯狂,美股市场的核心叙事:资金从高估值纯软体股大规模轮动至AI硬体基础设施、记忆体存储与能源板块。 #赢家阵营:AI基础设施全面爆发 记忆体与存储产业(SNDK、MU、STX、WDC) SanDisk以惊人的142%涨幅领跑整个市场,这反映的是AI数据中心对企业级SSD需求的爆发性成长。2026年AI模型训练与推理已进入全面商用化阶段,市场不再争论AI是否会成长,而是聚焦于「算力、存储、电力谁先不够用」的问题。 SanDisk作为企业级固态硬碟主要的厂商之一,直接受益于这波升级潮,财报显示数据中心相关营收出现结构性跳升。 Micron上涨45%则是HBM(高频宽记忆体)供不应求的直接体现。HBM已成为AI训练不可或缺的关键零组件,而Micron是这个领域的主要供应商之一。市场过去将记忆体视为典型周期股,如今正重新将其定价为AI结构性成长标的。 Seagate与Western Digital同样上涨45%至48%,反映的是云端大规模存储扩建对近线硬碟的庞大需求,AI生成的数据量呈指数级成长,冷存储需求随之暴增。 半导体设备(LRCX) Lam Research上涨36%受益于先进制程与记忆体资本支出的双重复苏。这家公司高度暴露于NAND与DRAM设备市场,当记忆体厂商重启扩产,设备订单自然满载。地缘政治因素反而强化了「在地制造」的设备需求,各国建立本土半导体产能的政策进一步推升订单能见度。 #AI电力与能源链(BE、CCJ、IREN、VG) Bloom Energy以74%的涨幅位居第二,核心逻辑是AI数据中心「缺电」已成为新的产业瓶颈。其固态氧化物燃料电池特别适合数据中心的备用与分散式供电场景,在电网容量不足的情况下提供关键补充。Hyperscaler与主权AI专案同步扩张,但电力基础设施的建设速度远跟不上算力扩张,这让Bloom Energy的","plainDigest":"2026的第一个月其实已经颇疯狂,美股市场的核心叙事:资金从高估值纯软体股大规模轮动至AI硬体基础设施、记忆体存储与能源板块。 #赢家阵营:AI基础设施全面爆发 记忆体与存储产业(SNDK、MU、STX、WDC) SanDisk以惊人的142%涨幅领跑整个市场,这反映的是AI数据中心对企业级SSD需求的爆发性成长。2026年AI模型训练与推理已进入全面商用化阶段,市场不再争论AI是否会成长,而是聚焦于「算力、存储、电力谁先不够用」的问题。 SanDisk作为企业级固态硬碟主要的厂商之一,直接受益于这波升级潮,财报显示数据中心相关营收出现结构性跳升。 Micron上涨45%则是HBM(高频宽记忆体)供不应求的直接体现。HBM已成为AI训练不可或缺的关键零组件,而Micron是这个领域的主要供应商之一。市场过去将记忆体视为典型周期股,如今正重新将其定价为AI结构性成长标的。 Seagate与Western Digital同样上涨45%至48%,反映的是云端大规模存储扩建对近线硬碟的庞大需求,AI生成的数据量呈指数级成长,冷存储需求随之暴增。 半导体设备(LRCX) Lam Research上涨36%受益于先进制程与记忆体资本支出的双重复苏。这家公司高度暴露于NAND与DRAM设备市场,当记忆体厂商重启扩产,设备订单自然满载。地缘政治因素反而强化了「在地制造」的设备需求,各国建立本土半导体产能的政策进一步推升订单能见度。 #AI电力与能源链(BE、CCJ、IREN、VG) Bloom Energy以74%的涨幅位居第二,核心逻辑是AI数据中心「缺电」已成为新的产业瓶颈。其固态氧化物燃料电池特别适合数据中心的备用与分散式供电场景,在电网容量不足的情况下提供关键补充。Hyperscaler与主权AI专案同步扩张,但电力基础设施的建设速度远跟不上算力扩张,这让Bloom Energy的","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769945279366,"gmtModify":1769947230354,"symbols":["CRWV","MRNA","GOOGL","RIVN","MDA","LRCX","ASTS"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/c82ca7844ddfc861edff269518457a3c","width":"1080","height":"1206"}],"repostCount":0,"viewCount":1956,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/528074237904056","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":3257,"displayRows":4,"foldSize":0,"authorId":"4192713077052572"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.524416268361880","cardData":[{"tweetId":"524416268361880","author":{"authorId":"3551233200528073","idStr":"3551233200528073","name":"投阅笔记","avatar":"https://static.tigerbbs.com/880e7458e2b86083ea5fcaee8dd335ea","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"Star Contributor","description":"Published at least 3 PICK posts (or 10 IDEA posts) and, within the past 30 days, posted at least 1 PICK post (or 4 IDEA posts) and 1 comment","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.28","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3(或有料帖>=10),且30天内发表过至少一篇精华帖(或4篇有料帖)并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.03.05","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"fanSize":2006,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$ </a> Moderna, Inc.公布的最新五年随访数据显示,其研发的Intismeran Autogene与默沙东的Keytruda(帕博利珠单抗)联合疗法,在主要临床终点指标上展现出持续性的改善效果。这一长期研究结果进一步验证了该组合疗法在相应适应症中的治疗潜力与持久性优势。","plainDigest":"$Moderna, Inc.(MRNA)$ Moderna, Inc.公布的最新五年随访数据显示,其研发的Intismeran Autogene与默沙东的Keytruda(帕博利珠单抗)联合疗法,在主要临床终点指标上展现出持续性的改善效果。这一长期研究结果进一步验证了该组合疗法在相应适应症中的治疗潜力与持久性优势。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1769057994667,"gmtModify":1769057997536,"symbols":["MRNA"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/638ac52e9dc30f2d2b05e08d45680b72","width":"588","height":"1112"}],"repostCount":0,"viewCount":1777,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/524416268361880","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":244,"displayRows":4,"foldSize":0,"authorId":"3551233200528073"}],"position":0}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20806084","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000047-MRNA","pdf_url":"","pub_time":1772673641000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/0001682852-26-000047-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000047/mrna-20260303.htm","primary":true,"translateUrl":"","linkName":"mrna-20260303.htm","type":"8-K","id":"NTFILEEJQjzxBLz6iSscSw","market":"us","size":36104}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-05 09:20","pubTimestamp":1772673641,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement","summary_zh":"项目1.01:订立重大最终协议","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20784451","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326001610-MRNA","pdf_url":"","pub_time":1772427600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326001610/0001959173-26-001610-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326001610/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE5Eos9adRKb78CrHy","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-03-02 13:00","pubTimestamp":1772427600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20755926","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917326001320-MRNA","pdf_url":"","pub_time":1771822800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 | Moderna高管Hoge Stephen拟减持160009股,总价约781.5万美元","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326001320/0001959173-26-001320-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"Form 144 | Moderna高管Hoge Stephen拟减持160009股,总价约781.5万美元","gpt_en_title":"Form 144 | Moderna's Officer Hoge Stephen proposes to sell 160,009 Shares, with a total value of approximately $7.81 Million.","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917326001320/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEEaQeaC9o8JxnP6un","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-02-23 13:00","pubTimestamp":1771822800,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","is_gpt_notice":1,"gpt_icon":1},{"cdn_pdf":false,"hasAttachments":true,"id":"20753184","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000034-MRNA","pdf_url":"","pub_time":1771563600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"MRNA","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/0001682852-26-000034-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/modernaforms-8feb2026.htm","primary":true,"translateUrl":"","linkName":"modernaforms-8feb2026.htm","type":"S-8","id":"NTFILE7LEPwbwDs6hcQNww","market":"us","size":47959},{"description":"","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/exfilingfees022026.htm","primary":false,"translateUrl":"","linkName":"exfilingfees022026.htm","type":"EX-FILING FEES","id":"NTFILEFw34btnarpWmMBLB","market":"us","size":17098},{"description":"EX-5.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/exhibit51opinionfors-8gp22.htm","primary":false,"translateUrl":"","linkName":"exhibit51opinionfors-8gp22.htm","type":"EX-5.1","id":"NTFILEEpLjotxgLvCujHbe","market":"us","size":8663},{"description":"EX-23.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/exhibit231eys-8consent22026.htm","primary":false,"translateUrl":"","linkName":"exhibit231eys-8consent22026.htm","type":"EX-23.1","id":"NTFILEE6TBk15ec7jF7cek","market":"us","size":2707},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000034/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILE96gYyL3DPFaQe2Kk","market":"us","size":13323}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2026-02-20 13:00","pubTimestamp":1771563600,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20753141","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000033-MRNA","pdf_url":"","pub_time":1771563600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"MRNA","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/0001682852-26-000033-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm","primary":true,"translateUrl":"","linkName":"mrna-20251231.htm","type":"10-K","id":"NTFILECQyUkgqA5BzEL28K","market":"us","size":2677412},{"description":"EX-4.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit4212312025.htm","primary":false,"translateUrl":"","linkName":"exhibit4212312025.htm","type":"EX-4.2","id":"NTFILE4yCNGf3WRHt4Z8n5","market":"us","size":20605},{"description":"EX-10.16","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit1016esppplan.htm","primary":false,"translateUrl":"","linkName":"exhibit1016esppplan.htm","type":"EX-10.16","id":"NTFILEFjhP7uhaFpdiLWKJ","market":"us","size":46160},{"description":"EX-19","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit19insidertradingpol.htm","primary":false,"translateUrl":"","linkName":"exhibit19insidertradingpol.htm","type":"EX-19","id":"NTFILE5yQcNYJKwUQjRALo","market":"us","size":43077},{"description":"EX-21.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit211subsidiaries1231.htm","primary":false,"translateUrl":"","linkName":"exhibit211subsidiaries1231.htm","type":"EX-21.1","id":"NTFILEEBz3oy58pPSj9B2Q","market":"us","size":16869},{"description":"EX-23.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit23112312025.htm","primary":false,"translateUrl":"","linkName":"exhibit23112312025.htm","type":"EX-23.1","id":"NTFILE9oSCeqLK5QSESZvT","market":"us","size":5458},{"description":"EX-31.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit31112312025.htm","primary":false,"translateUrl":"","linkName":"exhibit31112312025.htm","type":"EX-31.1","id":"NTFILE4rPWJZVPRbsf8ur3","market":"us","size":9455},{"description":"EX-31.2","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit31212312025.htm","primary":false,"translateUrl":"","linkName":"exhibit31212312025.htm","type":"EX-31.2","id":"NTFILEF1QPA7WayrmRG7sY","market":"us","size":9136},{"description":"EX-32.1","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit32112312025.htm","primary":false,"translateUrl":"","linkName":"exhibit32112312025.htm","type":"EX-32.1","id":"NTFILE8UHm1C4BLHcZuuBy","market":"us","size":6484},{"description":"EX-32.2","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/exhibit32212312025.htm","primary":false,"translateUrl":"","linkName":"exhibit32212312025.htm","type":"EX-32.2","id":"NTFILE4EZkEnLCiXK5Uprj","market":"us","size":6472},{"description":"","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILEEAEpEch3519K8bhS","market":"us","size":21831},{"description":"","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231_g1.jpg","primary":false,"translateUrl":"","linkName":"mrna-20251231_g1.jpg","type":"GRAPHIC","id":"NTFILE8iV29LB5AYvX7t4z","market":"us","size":63925},{"description":"","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231_g2.jpg","primary":false,"translateUrl":"","linkName":"mrna-20251231_g2.jpg","type":"GRAPHIC","id":"NTFILE3BdgKkjRJayaMW4W","market":"us","size":54660},{"description":"","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231_g3.jpg","primary":false,"translateUrl":"","linkName":"mrna-20251231_g3.jpg","type":"GRAPHIC","id":"NTFILEGHfxn7fxgj2h7MtJ","market":"us","size":120464},{"description":"","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231_g4.jpg","primary":false,"translateUrl":"","linkName":"mrna-20251231_g4.jpg","type":"GRAPHIC","id":"NTFILEGVBvfKckVNNcG2Bm","market":"us","size":263258},{"description":"","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231_g5.jpg","primary":false,"translateUrl":"","linkName":"mrna-20251231_g5.jpg","type":"GRAPHIC","id":"NTFILEFsk52z5kDL5KXWwy","market":"us","size":153784}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-02-20 13:00","pubTimestamp":1771563600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20735003","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000015-MRNA","pdf_url":"","pub_time":1770958800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000015/0001682852-26-000015-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000015/exhibit9912025q4pressrelea.htm","primary":true,"translateUrl":"","linkName":"exhibit9912025q4pressrelea.htm","type":"EX-99.1","id":"NTFILEBoT6stF5tfTMpHku","market":"us","size":164349},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000015/mrna-20260213.htm","primary":false,"translateUrl":"","linkName":"mrna-20260213.htm","type":"8-K","id":"NTFILEG6HNnB5K5r4TtjBX","market":"us","size":30069}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-13 13:00","pubTimestamp":1770958800,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项:经营业绩和财务状况;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20727446","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000012-MRNA","pdf_url":"","pub_time":1770764567000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/0001682852-26-000012-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/exhibit991-02102026.htm","primary":true,"translateUrl":"","linkName":"exhibit991-02102026.htm","type":"EX-99.1","id":"NTFILE2TtKX4MQXKpzDfSu","market":"us","size":22481},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000012/mrna-20260203.htm","primary":false,"translateUrl":"","linkName":"mrna-20260203.htm","type":"8-K","id":"NTFILEDHFvyay5LL1njumf","market":"us","size":30131}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-11 07:02","pubTimestamp":1770764567,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项:法规FD披露;项目8.01:其他事件;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20623780","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000007-MRNA","pdf_url":"","pub_time":1768194000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000007/0001682852-26-000007-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000007/exhibit991-01122026.htm","primary":true,"translateUrl":"","linkName":"exhibit991-01122026.htm","type":"EX-99.1","id":"NTFILEBnB2rGdJF82dGMnA","market":"us","size":26335},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000007/mrna-20260112.htm","primary":false,"translateUrl":"","linkName":"mrna-20260112.htm","type":"8-K","id":"NTFILE9ETNDu2LQK9YPwb1","market":"us","size":31561}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-12 13:00","pubTimestamp":1768194000,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02:经营业绩和财务状况;第7.01项:法规FD披露;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20600634","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285226000003-MRNA","pdf_url":"","pub_time":1767589200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/0001682852-26-000003-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/exhibit991-01052026lettert.htm","primary":true,"translateUrl":"","linkName":"exhibit991-01052026lettert.htm","type":"EX-99.1","id":"NTFILEGCohV7pXpQrK5ANk","market":"us","size":38442},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/mrna-20260105.htm","primary":false,"translateUrl":"","linkName":"mrna-20260105.htm","type":"8-K","id":"NTFILEE2gFnxMWkqAka4M4","market":"us","size":29802},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/image_0a.jpg","primary":false,"translateUrl":"","linkName":"image_0a.jpg","type":"GRAPHIC","id":"NTFILE2dNFW2WZyRSN15xT","market":"us","size":29394},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285226000003/imagea.jpg","primary":false,"translateUrl":"","linkName":"imagea.jpg","type":"GRAPHIC","id":"NTFILEEvPKsCEPFXAPzZy7","market":"us","size":2451}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-05 13:00","pubTimestamp":1767589200,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项:法规FD披露;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20520188","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917325007675-MRNA","pdf_url":"","pub_time":1765429200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917325007675/0001959173-25-007675-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1400240/000195917325007675/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEH4Jq9hdFpAAvbZV1","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-12-11 13:00","pubTimestamp":1765429200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20508279","market":"us","labels":[],"media":"sec.gov","original_id":"AN195917325007584-MRNA","pdf_url":"","pub_time":1765256400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"MRNA","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000195917325007584/0001959173-25-007584-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000195917325007584/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE3AKVe1D1XrgdLynm","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2025-12-09 13:00","pubTimestamp":1765256400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20446476","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828025053816-MRNA","pdf_url":"","pub_time":1764019779000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/0001628280-25-053816-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/moderna-creditandguarantya.htm","primary":true,"translateUrl":"","linkName":"moderna-creditandguarantya.htm","type":"EX-10","id":"NTFILE4d4BNPcNj9mzCtMz","market":"us","size":1885109},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053816/mrna-20251119.htm","primary":false,"translateUrl":"","linkName":"mrna-20251119.htm","type":"8-K","id":"NTFILE2sFNpxKhtcaDxkZ8","market":"us","size":33161}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-25 05:29","pubTimestamp":1764019779,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项:签订重大最终协议;第2.03项:直接财务义务或注册人资产负债表外安排下的义务的产生;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20433695","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828025053318-MRNA","pdf_url":"","pub_time":1763614800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053318/0001628280-25-053318-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053318/exhibit9912025analystday.htm","primary":true,"translateUrl":"","linkName":"exhibit9912025analystday.htm","type":"EX-99","id":"NTFILESznGvojU34Pu9h5c","market":"us","size":32830},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025053318/mrna-20251120.htm","primary":false,"translateUrl":"","linkName":"mrna-20251120.htm","type":"8-K","id":"NTFILE48auKr6G9kP4NnDT","market":"us","size":29811}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-20 13:00","pubTimestamp":1763614800,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01项:法规FD披露;项目9.01:财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20406061","market":"us","labels":[],"media":"sec.gov","original_id":"AN162828025052055-MRNA","pdf_url":"","pub_time":1763010000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"MRNA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025052055/0001628280-25-052055-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000162828025052055/mrna-20251112.htm","primary":true,"translateUrl":"","linkName":"mrna-20251112.htm","type":"8-K","id":"NTFILEVW7nzU941wMNCPfJ","market":"us","size":32366}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-13 13:00","pubTimestamp":1763010000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07:将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20379440","market":"us","labels":[],"media":"sec.gov","original_id":"AN168285225000075-MRNA","pdf_url":"","pub_time":1762405200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"MRNA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/mrna-20250930.htm","primary":true,"translateUrl":"","linkName":"mrna-20250930.htm","type":"10-Q","id":"NTFILECoUUJMTfVhoCgqG3","market":"us","size":1467110},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/exhibit3119302025.htm","primary":false,"translateUrl":"","linkName":"exhibit3119302025.htm","type":"EX-31.1","id":"NTFILEJ8pTERTsGWj2oyaW","market":"us","size":9049},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/exhibit3129302025.htm","primary":false,"translateUrl":"","linkName":"exhibit3129302025.htm","type":"EX-31.2","id":"NTFILEwMh6VJmMc2w1pTPj","market":"us","size":8989},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/exhibit3219302025.htm","primary":false,"translateUrl":"","linkName":"exhibit3219302025.htm","type":"EX-32.1","id":"NTFILEES9tbrnLCKU5AcP6","market":"us","size":8123},{"description":"","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/mrna-20250930_g1.jpg","primary":false,"translateUrl":"","linkName":"mrna-20250930_g1.jpg","type":"GRAPHIC","id":"NTFILEFFFVkEp5qXNbfuvs","market":"us","size":63925},{"description":"","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1682852/000168285225000075/mrna-20250930_g2.jpg","primary":false,"translateUrl":"","linkName":"mrna-20250930_g2.jpg","type":"GRAPHIC","id":"NTFILEDzzmxjoTMH3TT9FS","market":"us","size":264039}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-06 13:00","pubTimestamp":1762405200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.modernatx.com;www.investors.modernatx.com","stockEarnings":[{"period":"1week","weight":-0.0082},{"period":"1month","weight":0.2713},{"period":"3month","weight":0.8123},{"period":"6month","weight":1.2709},{"period":"1year","weight":0.525},{"period":"ytd","weight":0.8104}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0377},{"period":"3month","weight":-0.023},{"period":"6month","weight":0.0132},{"period":"1year","weight":0.1918},{"period":"ytd","weight":-0.0233}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸(信使核糖核酸)医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年,该公司以前所未有的速度和效率开发出药物,包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队,以负责任的方式改变人类健康的未来,该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.112326},{"month":2,"riseRate":0.375,"avgChangeRate":0.016129},{"month":3,"riseRate":0.5,"avgChangeRate":0.024603},{"month":4,"riseRate":0.714286,"avgChangeRate":0.123955},{"month":5,"riseRate":0.571429,"avgChangeRate":0.06219},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.025027},{"month":7,"riseRate":0.714286,"avgChangeRate":0.106584},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.089569},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.018964},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.032236},{"month":11,"riseRate":0.714286,"avgChangeRate":0.206001},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.033274}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"aProfile":null}}}